Diabetic Nephropathy
Pyridorin results reported; new CEO named at pharmaceutical firm
Published in Obesity and Diabetes Week, September 15th, 2003
Schotzinger, who will also serve on BioStratum's board of directors, joined Biostratum in November 2000 as VP and chief medical officer and was appointed president and chief operating officer in October 2002.
Prior to joining BioStratum, Schotzinger held positions of increasing responsibility at Abbott Laboratories. Commenting on Schotzinger's promotion, J. William Freytag, PhD, chairman of BioStratum's board of directors, said, "Since Bob joined BioStratum, we have been impressed...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Bone Mineral Density
Healthy weight and exercise maintains bone mineral density late in life - Insulin Resistance
Insulin resistance syndrome increases risk of coronary artery disease - Complementary and Alternative Medicine
Mechanism by which chromium picolinate may enhance insulin sensitivity revealed - Diabetes Therapy
Blood pressure and lipid treatment guidelines in diabetic patients discussed - Obesity Epidemiology
High prevalence of Ala54Thr FABP2 polymorphism high in Tongans - Reproductive Medicine
Weight loss may help resolve reproductive disorders in obese women - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
